Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

A new bill to improve the way Medicare Advantage (MA) providers determine patients’ health risks, to eliminate overpayment.

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

People who get subsidized coverage through what’s known as Medicare Savings Programs get to keep hundreds of dollars per ...

GOP lawmakers in 10 states have refused for a decade to expand Medicaid under the Affordable Care Act. But when President Trump got another whack at Obamacare, these holdout states went unrewarded.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, ...